World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
142
Citations
124468
World Ranking
1530
National Ranking
889

Overview

Norman Wolmark is affiliated with the University of Pittsburgh in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, and Radiology, Nuclear Medicine and Imaging.

Wolmark's work covers multiple main topics, including Breast Cancer Treatment Studies, Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Genetic factors in colorectal cancer, Cancer Treatment and Pharmacology, and Advanced Breast Cancer Therapies.

They have published extensively in several leading journals. The most frequent publication venues include the Journal of Clinical Oncology with 74 publications, Cancer Research with 24 publications, Clinical Cancer Research with 10 publications, Annals of Oncology with 8 publications, and JNCI Journal of the National Cancer Institute with 6 publications.

Their recent notable papers are:

  • Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer, 2021, New England Journal of Medicine
  • Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials, 2021, The Lancet Oncology
  • Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03), 2021, Journal of Clinical Oncology
  • Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial, 2022, Annals of Oncology
  • Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer, 2021, JAMA Oncology

Frequent collaborators include Greg Yothers, Eleftherios P. Mamounas, Peter C. Lucas, Charles E. Geyer, and Thomas J. George. The collaboration counts range from 47 to 63 joint works with these co-authors.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    Soonmyung Paik;Steven Shak;Gong Tang;Chungyeul Kim

  • Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

    Edward H. Romond;Edith A. Perez;John Bryant;Vera J. Suman

  • Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

    Patricia Cortazar;Lijun Zhang;Michael Untch;Keyur Mehta

  • Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    Soonmyung Paik;Gong Tang;Steven Shak;Chungyeul Kim

  • Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

    David N. Krag;Stewart J. Anderson;Thomas B. Julian;Ann M. Brown

  • Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    Gunter Von Minckwitz;Chiun Sheng Huang;Max S. Mano;Sibylle Loibl

  • Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

    Priya Rastogi;Stewart J. Anderson;Harry D. Bear;Charles E. Geyer

  • Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer.

    Fisher B;Anderson S;Redmond Ck;Wolmark N

  • Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

    Victor G. Vogel;Joseph P. Costantino;D. Lawrence Wickerham;D. Lawrence Wickerham;Walter M. Cronin

  • Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

    B Fisher;C Redmond;E R Fisher;M Bauer

  • Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation

    Bernard Fisher;Jong-Hyeon Jeong;Stewart Anderson;John Bryant

  • The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

    Harry D. Bear;Stewart Anderson;Ann Brown;Roy Smith

  • Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.

    Bernard Fisher;Norman Wolmark;Howard Rockette;Carol Redmond

  • Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

    David N Krag;Stewart J Anderson;Thomas B Julian;Ann M Brown

  • Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

    Bernard Fisher;James Dignam;Norman Wolmark;D Lawrence Wickerham

  • Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

    J. Philip Kuebler;H. Samuel Wieand;Michael J. O'Connell;Roy E. Smith

  • Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer : National surgical adjuvant breast and bowel project protocol B-27

    Harry D. Bear;Stewart Anderson;Roy E. Smith;Charles E. Geyer

  • Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17

    B. Fisher;J. Dignam;N. Wolmark;E. Mamounas

  • Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

    Andrew N.J. Tutt;Judy E. Garber;Bella Kaufman;Giuseppe Viale

Frequent Co-Authors

Joseph P. Costantino
Joseph P. Costantino University of Pittsburgh
Eleftherios P. Mamounas
Eleftherios P. Mamounas University of Florida Health
Bernard Fisher
Bernard Fisher University of Pittsburgh
Soonmyung Paik
Soonmyung Paik Yonsei University
Sandra M. Swain
Sandra M. Swain Georgetown University Medical Center
Louis Fehrenbacher
Louis Fehrenbacher Kaiser Permanente
Patricia A. Ganz
Patricia A. Ganz University of California, Los Angeles
Charles E. Geyer
Charles E. Geyer University of Pittsburgh
Edwin R. Fisher
Edwin R. Fisher University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can offer flexibility and affordability to aspiring healthcare professionals. For registered nurses looking to advance their careers, the cheapest rn to bsn online programs provide a budget-friendly way to obtain a Bachelor of Science in Nursing without the high expenses of traditional schooling.

If you are considering entering the nursing field but hold a non-nursing bachelor’s degree, entry level msn programs online offer accelerated pathways to become a nurse and earn a master’s degree.

Prospective students concerned about competitive admissions may benefit from researching the easiest rn program options. These programs typically have higher acceptance rates, making entry into the nursing profession more accessible.

For those interested in healthcare from an administrative perspective, pursuing medical billing and coding is a popular alternative. Many schools provide online programs, and you can explore financial aid for medical billing and coding to help offset costs and support your studies.

Best Scientists Citing Norman Wolmark

Trending Scientists

Recently Published Articles